Lung cancer: open trials in Georgia

13 open trials have a site in Georgia. Registry data; only the trial team decides who can take part.

NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Trial Treatment · Phase 2 · Jazz Pharmaceuticals
JSC Vian- Krystyna Kiel Oncology Center, Kutaisi · Ltd "Todua Clinic", Tbilisi · Cancer Research Centre, Tbilisi · LTD Caucasus Medical Centre, Tbilisi · Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic LLC, Tbilisi
Registry updated 2026-11-04
NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Trial Treatment · Phase 2/3 · BioNTech SE
High Technology Hospital Medcenter LTD, Batumi · New Hospitals, Tbilisi · LTD Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi · Cancer Research Centre, Tbilisi · Llc Todua Clinic, Tbilisi
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Local Institution - 007-790, Batumi · Local Institution - 007-063, Tbilisi · Local Institution - 007-795, Tbilisi · Local Institution - 007-065, Tbilisi · Institute of Clinical Oncology - Tbilisi, Tbilisi · Local Institution - 007-789, Tbilisi
Registry updated 2026-10-30
NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Trial Treatment · Phase 1 · SystImmune Inc.
LTD High Technology Hospital Medcenter, Batumi · JSC Vian, Kutaisi · LLC "Caucasus Medical Centre", Tbilisi · LTD "Pineo Medical Ecosystem", Tbilisi · LTD "New Hospitals", Tbilisi
Registry updated 2026-10-30
NCT05098132
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Trial Treatment · Phase 1/2 · Synthekine
LTD High Technology Hospital Medcenter, Batumi · Israel- Georgian Medical Research Clinic Healthycore, Tbilisi · Institute of Clinical Oncology (ICO), Tbilisi · Caraps Medline, Ltd (JSC VIAN), Tbilisi
Registry updated 2026-10-29
NCT06996782
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 1/2 · AstraZeneca
Batumi · Tbilisi
Registry updated 2026-10-28
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
ARENSIA Exploratory Medicine LLC, Tbilisi
Registry updated 2026-10-28
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
High Technology Hospital Medcenter (Site 1203), Batumi · JSC "Vian" (Site 1211), Kutaisi · Todua Clinic, LLC (Site 1204), Tbilisi · New Hospitals (Site 1200), Tbilisi · Cancer Research Centre. Mardaleishvili Medical Centre (Site 1205), Tbilisi · Tbilisi Institute of Medicine (Site 1206), Tbilisi · TSMU and Ingorokva High Medical Technology University Clinic LTD (Site 1201), Tbilisi · American Hospital Network LLC (Site 1208), Tbilisi · "Institute of Clinical Oncology" LTD (Site 1210), Tbilisi · Caucasus Medical Centre (Site 1202), Tbilisi
Registry updated 2026-10-26
NCT07625644
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Trial Treatment · Phase 3 · SystImmune Inc.
Caucasus Medical Centre, Tbilisi · Llc Todua Clinic, Tbilisi · LTD "New Hospitals", Tbilisi · Pineo Medical Ecosystem LtD, Tbilisi · The First Medical Clinic LLC, Tbilisi · LTD High Technology Hospital Medcenter, Tbilisi
Registry updated 2026-10-15
NCT06868277
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · AstraZeneca
Tbilisi
Registry updated 2026-09-25
NCT07391670
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
Trial Treatment · Phase 1 · AstraZeneca
Batumi · Tbilisi
Registry updated 2026-09-24
NCT06095583
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Trial Treatment · Phase 3 · Shanghai Junshi Bioscience Co., Ltd.
LTD "New Hospitals", Tbilisi · Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi · ISR-GEO Med Res Clin Healthycore, Tbilisi · "TIM - Tbilisi Institute of Medicine" LTD, Tbilisi · ICO-Institute of Clinical Oncology - Hospital, Tbilisi · LTD "Israel-Georgian Medical Research Clinic Healthycore", Tbilisi · Multprofil Clinic Consilium Medulla, Tbilisi
Registry updated 2026-07-27
NCT07627022
Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer
Trial Treatment · University Hospital Schleswig-Holstein
Radiation Oncology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi
Registry updated 2026-06-04

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error